We conclude that periostin may be a potential target for future therapeutic intervention to obstruct tumoral lymphatic invasion, angiogenesis, and lymphangiogenesis in HNSCC patients. The gene discussed is POSTN; the disease is head and neck squamous cell carcinoma.